Developer docs
API playgroundTry for free, no card

Search company profiles

Neural Cloud Solutions

Full company profile

uuid0099ak8

Namestring
Neural Cloud Solutions
Legal namestring
NeuralCloud Solutions Inc.
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Neural Cloud Solutions Inc. is a Canadian AI/ML company that commercializes a proprietary neural-network ECG signal-processing platform under the brand MaxYield. Founded in 2024 and headquartered in Toronto with a secondary office in Calgary, the company originated from University of Alberta research into cleaning noisy continuous ECG recordings captured by wearable devices, and operates as a wholly owned subsidiary of AI/ML Innovations Inc. (CSE: AIML). The core technology is a patented, device-agnostic intelligence layer that maps raw ECG signals through motion artifact, baseline wander, and electrode noise to isolate true cardiac waveforms, then outputs beat-by-beat PQRST onsets and offsets plus derived intervals such as PR, QRS, QT, QTc, ST, and HRV metrics. The same neural-network methodology has been extended to photoplethysmography under MaxYield-PPG for consumer wearables, and visualization/reporting and clinical-workflow layers are offered as Insight360 and CardioYield.

The company sells primarily to four vertical and business-unit segments: healthcare providers and cardiologists using Holter, patch, event, and ambulatory monitors; wearable device manufacturers embedding ECG/PPG intelligence into smartwatches and rings; clinical research organizations and academic institutions running cardiac studies; and veterinary, sports medicine, and OEM partners. Revenue mechanics combine subscription-based API/SDK/CDK access, OEM enterprise licensing for device embedding, and performance-based partner/reseller commissions. Distribution is global via REST API cloud services and on-device SDKs, with exclusive regional distribution through Intelimed.ai SpA in Chile (and non-exclusive coverage across Latin America) and reseller integration through a European digital health platform.

Commercial evidence of traction includes over 1.15 billion heartbeats processed platform-wide, named clinical endorsements from cardiologists at St. Paul's Hospital Vancouver and St. Michael's Hospital, a public white paper reporting MaxYield ranked second among 15 certified cardiology technologists, HIPAA/GDPR/PIPEDA compliance, data hosted on AWS, FDA Class II SaMD review pending, and a staged Holter rollout with Lakeshore Cardiology contingent on Health Canada clearance. Pricing is not publicly disclosed and a self-service free trial supports product-led evaluation.

Short descriptiontext

Neural Cloud Solutions is a Toronto-based AI subsidiary of AI/ML Innovations Inc. that commercializes the patented MaxYield neural network for ECG and PPG signal cleaning, PQRST waveform labeling, and clinical visualization sold to clinicians, researchers, wearable OEMs, and channel partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ECG signal processing, AI cardiac diagnostics, neural network analysis, wearable cardiac monitoring, Holter monitoring software
Industry3 codes
1SaMD – Imaging & Signal Analysis (AI/ML)
CodeHLACANAGPrimaryYes
2AI/Analytics for RPM (Risk Stratification, Alerts, Predictive)
CodeHLACAFAMPrimaryNo
3On-Device Inference Runtimes & SDKs (mobile/embedded)
CodeHDAAAJABPrimaryNo
NAICS code3 codes
  • Computer Systems Design and Related Services54151
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518210
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Services-Computer Processing & Data Preparation7374
  • Services-Computer Integrated Systems Design7373
Product category
AI Cardiac Signal Processing Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1API/SDK/CDK Subscriptions
TypeSubscription Recurring
Description

Cloud-based processing and on-device SDK licensing for ECG signal analysis. Usage-based and subscription components with monthly or annual billing.

theneuralcloud.com
2Enterprise Licensing
TypeLicensing Royalties
Description

Custom enterprise agreements with device manufacturers and healthcare software companies for embedding MaxYield technology.

theneuralcloud.com
3Partner/Reseller Revenue Share
TypeSubscription Recurring
Description

Performance-based partner program with commissions on closed business, higher rates for continued involvement.

theneuralcloud.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1Free Trial
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free trial with account creation and activation process. Users can upload ECG (.edf) files for analysis within Admin Console.

theneuralcloud.com
2Paid Subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Monthly or annual paid subscriptions with automatic renewal. Price adjustments require 14 days notice.

theneuralcloud.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1MaxYield
Description

Proprietary neural network intelligence layer that ingests raw ECG recordings from any device and returns clean, neuralized signals with beat-by-beat PQRST data. Includes MaxYield-ECG for electrocardiogram analysis and MaxYield-PPG for photoplethysmography signals.

theneuralcloud.com
+2 more records
Core offering1 text field

Neural Cloud Solutions develops and commercializes the MaxYield neural network platform for AI-powered ECG and PPG signal processing. The platform applies patented machine learning to clean noisy cardiac recordings from any device and deliver beat-by-beat PQRST labeling with precise onset/offset identification and time-series intervals (RR, PR, QT, QTc, ST). Products are delivered via REST API, SDK, and CDK integration to healthcare providers, medical device manufacturers, OEMs, and research organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Processing speed: 200,000 heartbeats analyzed in less than 2 minutes
+3 more records
Product overview1 text field

Neural Cloud Solutions offers a portfolio of AI-powered ECG signal processing products centered on the MaxYield™ platform. The core offering is MaxYield-ECG, a device-agnostic intelligence layer that applies patented neural network technology to clean ECG signals and deliver beat-by-beat PQRST labeling with time-series intervals. MaxYield-PPG extends this capability to photoplethysmography signals for wearables. Insight360 serves as the visualization and reporting layer, while CardioYield provides clinical review workflows. The company also offers vertical-specific solutions for animal/veterinary ECG, sports medicine, cardiac research, and wearable technology integration. All products are delivered via REST API, SDK, or CDK integration, positioning the company as a B2B technology provider to healthcare software companies, device manufacturers, and clinical organizations. Neural Cloud Solutions is a wholly owned subsidiary of AI/ML Innovations Inc. (CSE: AIML).

Product and service8 records
1MaxYield-ECG
CategoryCore product
Description

Device-agnostic ECG intelligence layer that maps through signal noise to isolate true ECG waveforms and delivers rapid, in-depth beat-by-beat PQRST labeling and time-series intervals (RR, PR, QT, QTc, ST). Delivered via REST API, SDK, or CDK integration as an additive layer for existing ECG workflows used by healthcare providers, device manufacturers, and OEMs.

2MaxYield-PPG
CategoryCore product
Description

Photoplethysmography signal processing technology that applies Neural Cloud's neural network methodology to PPG signals from consumer wearables. Provides motion-artifact removal, heart-rate algorithm enhancement, ambient light interference compensation, skin tone adaptation, and HRV analysis for exercise-grade accuracy during high-intensity activities.

3Insight360
CategoryAdd-on module
Description

Visualization and reporting layer that transforms MaxYield's quantified ECG data into customizable dashboards and reports. Features drag-and-drop widgets, configurable formulas (QTc, HRV, ST analysis), reusable templates, and HTML/PDF export for rapid clinical interpretation and scaled reporting throughput.

4CardioYield
CategoryAdd-on module
Description

AI-powered ECG visualization platform driven by MaxYield signal-processing technology for clinical workflows. Integrates with Holter monitoring to enable review, editing, and approval of flagged cardiac events with automated report generation and standardized structured outputs.

5Animal & Veterinary ECG Solution
CategoryVertical-specific solution
Description

Species-specific, beat-level ECG intelligence for animal and veterinary applications. Species-aware neural networks trained on species-specific morphologies for canine, equine, feline, porcine, rodent, and non-human primates, handling motion-heavy environments and extreme heart rate variability.

6Wearable ECG Integration
CategoryVertical-specific solution
Description

ECG signal enhancement solution for wearable technology companies. Provides clean, isolated ECG signals from smartwatches, smart rings, chest straps, and patch monitors, enabling product differentiation through superior signal quality and actionable cardiac insights.

7Cardiac Research Solution
CategoryVertical-specific solution
Description

ECG analysis solution for preclinical, clinical research organizations, and academic cardiac disease studies. Automated beat-by-beat tabulation for large-scale studies with standardized labeling, noise removal, and reproducible results supporting regulatory submissions.

8Sports Medicine Solution
CategoryVertical-specific solution
Description

ECG neural network for sports medicine and athletic performance monitoring. Analyzes cardiac data during high-intensity workouts from wearables and patch monitors, providing real-time feedback, trend analysis, and early detection of cardiac abnormalities related to overtraining.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1European Digital Health Platform
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-25
Description

Reseller agreement to integrate and resell NeuralCloud's MaxYield ECG signal-processing technology for remote cardiac monitoring. Enables AI-driven ECG analysis to healthcare providers, transforming raw ECG signals into clean structured data for detecting cardiac abnormalities and supporting preventive cardiology.

stocktitan.net
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-18
Description

Research services agreement for AI-powered ECG signal processing in cardiovascular study examining heart rate variability in post-exertional malaise patients. NeuralCloud provides MaxYield platform to convert raw ECG recordings from PDF format into structured European Data Format for downstream HRV analysis. Findings expected to be published within the coming year.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-02-18
Description

Distribution agreement appointing Intelimed as exclusive distributor of Neural Cloud's cardiac software platforms (MaxYield, CardioYield, and Insight 360) in Chile and non-exclusive distributor across rest of Latin America. Targets hospitals, clinics, diagnostic providers, OEMs, telemedicine providers, and research institutions.

4Lakeshore Cardiology
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-12-12
Description

Non-binding Commercial Agreement Term Sheet to integrate CardioYield AI-powered ECG visualization platform driven by MaxYield signal-processing technology into Lakeshore Cardiology's clinical workflows for Holter monitoring. Staged rollout: internal validation, paid trial, full system integration, and commercial availability pending Health Canada clearance.

stocktitan.net
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

HeartBeam develops AI-enabled ECG technology for cardiac event detection and remote monitoring. Comparable as a small-cap digital health company focused on AI-ECG innovation, though with a more device-centric product strategy than Neural Cloud's platform-software approach.

TypeDirect peer
Description

Eko Health develops AI-powered cardiac analysis (LUCAS for murmurs, AI ECG algorithms) used in clinical and point-of-care settings. Directly comparable to Neural Cloud as another AI-first ECG analytics provider integrating with stethoscopes and digital cardiac workflows.

TypeDirect peer
Description

iRhythm (Zio) combines wearable patch cardiac monitoring with proprietary AI-based ECG analysis for long-duration recordings. Highly comparable in scale-to-noise handling for extended Holter monitoring, the exact niche Neural Cloud targets with its 14.5-day continuous-recording capability.

TypeDirect peer
Description

AliveCor (KardiaMobile) builds AI-driven ECG analysis for consumer and clinical use, applying machine learning to single-lead ECG signals. Closely comparable product category (AI ECG), with both companies competing to license signal-intelligence IP to clinicians and device OEMs.

TypeEmerging player
Description

Biotricity builds wearable cardiac monitoring devices (Bioflux) with cloud-based AI analysis for arrhythmia detection. Comparable in wearable-ECG + AI positioning though more vertically integrated on the hardware side than Neural Cloud's pure software/API approach.

TypeBroad incumbent
Description

GE Healthcare's MUSE cardiology information system and resting ECG portfolio is widely deployed across US hospitals. A broad incumbent competitor for ECG analysis budgets, bundling analysis software with hardware and EMR integration.

TypeBroad incumbent
Description

Philips operates a large cardiac monitoring business spanning IntelliVue patient monitors, Holter/ambulatory ECG, and the Cardiologs AI ECG platform. Broad incumbent in the same category with overlapping ECG analytics capabilities and well-established hospital relationships.

TypeDirect peer
Description

Cardiologs (acquired by Philips) provides cloud-based AI ECG interpretation for Holter and ambulatory recordings, marketed to cardiology practices and IDTFs. Directly comparable in additive-layer positioning and target customer base, now operating inside a large incumbent.

TypeBroad incumbent
Description

Preventice, now part of Boston Scientific, offers the BodyGuardian suite of wearable cardiac monitors with proprietary arrhythmia detection algorithms. Incumbent offering a vertically integrated monitor+AI+service stack that competes for IDTF and hospital Holter/ambulatory monitoring budgets.

TypeDirect peer
Description

VectraCor develops cloud-based AI ECG interpretation software (Vectraplex/EVOVIE) for clinicians. Comparable product offering (cloud ECG analysis) and customer segment (cardiologists and hospitals), though distributed primarily via direct enterprise sales.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Neural Cloud Solutions

AI Cardiac Signal Processing Softwaretheneuralcloud.com

Neural Cloud Solutions is a Toronto-based AI subsidiary of AI/ML Innovations Inc. that commercializes the patented MaxYield neural network for ECG and PPG signal cleaning, PQRST waveform labeling, and clinical visualization sold to clinicians, researchers, wearable OEMs, and channel partners.

What Neural Cloud Solutions does

Neural Cloud Solutions Inc. is a Canadian AI/ML company that commercializes a proprietary neural-network ECG signal-processing platform under the brand MaxYield. Founded in 2024 and headquartered in Toronto with a secondary office in Calgary, the company originated from University of Alberta research into cleaning noisy continuous ECG recordings captured by wearable devices, and operates as a wholly owned subsidiary of AI/ML Innovations Inc. (CSE: AIML). The core technology is a patented, device-agnostic intelligence layer that maps raw ECG signals through motion artifact, baseline wander, and electrode noise to isolate true cardiac waveforms, then outputs beat-by-beat PQRST onsets and offsets plus derived intervals such as PR, QRS, QT, QTc, ST, and HRV metrics. The same neural-network methodology has been extended to photoplethysmography under MaxYield-PPG for consumer wearables, and visualization/reporting and clinical-workflow layers are offered as Insight360 and CardioYield.

The company sells primarily to four vertical and business-unit segments: healthcare providers and cardiologists using Holter, patch, event, and ambulatory monitors; wearable device manufacturers embedding ECG/PPG intelligence into smartwatches and rings; clinical research organizations and academic institutions running cardiac studies; and veterinary, sports medicine, and OEM partners. Revenue mechanics combine subscription-based API/SDK/CDK access, OEM enterprise licensing for device embedding, and performance-based partner/reseller commissions. Distribution is global via REST API cloud services and on-device SDKs, with exclusive regional distribution through Intelimed.ai SpA in Chile (and non-exclusive coverage across Latin America) and reseller integration through a European digital health platform.

Commercial evidence of traction includes over 1.15 billion heartbeats processed platform-wide, named clinical endorsements from cardiologists at St. Paul's Hospital Vancouver and St. Michael's Hospital, a public white paper reporting MaxYield ranked second among 15 certified cardiology technologists, HIPAA/GDPR/PIPEDA compliance, data hosted on AWS, FDA Class II SaMD review pending, and a staged Holter rollout with Lakeshore Cardiology contingent on Health Canada clearance. Pricing is not publicly disclosed and a self-service free trial supports product-led evaluation.

Neural Cloud Solutions firmographics

Firmographics
Name
Neural Cloud Solutions
Legal name
NeuralCloud Solutions Inc.
Website
https://theneuralcloud.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
Neural Cloud Solutions is a Toronto-based AI subsidiary of AI/ML Innovations Inc. that commercializes the patented MaxYield neural network for ECG and PPG signal cleaning, PQRST waveform labeling, and clinical visualization sold to clinicians, researchers, wearable OEMs, and channel partners.
Ownership category
akta.pro rank

Neural Cloud Solutions industry classification

Industry
Product category
AI Cardiac Signal Processing Software
NAICS
Computer Systems Design and Related Services (54151), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Services-Computer Processing & Data Preparation (7374), Services-Computer Integrated Systems Design (7373)
akta.pro primary industry
SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
akta.pro secondary industries
AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM), On-Device Inference Runtimes & SDKs (mobile/embedded) (HDAAAJAB)

Keywords

  • ECG signal processing
  • AI cardiac diagnostics
  • Neural network analysis
  • Wearable cardiac monitoring
  • Holter monitoring software

Where Neural Cloud Solutions is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices3 records

Markets served

Neural Cloud Solutions business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. API/SDK/CDK Subscriptions: Cloud-based processing and on-device SDK licensing for ECG signal analysis. Usage-based and subscription components with monthly or annual billing.
  2. Enterprise Licensing: Custom enterprise agreements with device manufacturers and healthcare software companies for embedding MaxYield technology.
  3. Partner/Reseller Revenue Share: Performance-based partner program with commissions on closed business, higher rates for continued involvement.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree Trial
SubscriptionAnnualPaid Subscription

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

Neural Cloud Solutions product offering

Product offering

Core offering

Neural Cloud Solutions develops and commercializes the MaxYield neural network platform for AI-powered ECG and PPG signal processing. The platform applies patented machine learning to clean noisy cardiac recordings from any device and deliver beat-by-beat PQRST labeling with precise onset/offset identification and time-series intervals (RR, PR, QT, QTc, ST). Products are delivered via REST API, SDK, and CDK integration to healthcare providers, medical device manufacturers, OEMs, and research organizations.

Product overview

Neural Cloud Solutions offers a portfolio of AI-powered ECG signal processing products centered on the MaxYield™ platform. The core offering is MaxYield-ECG, a device-agnostic intelligence layer that applies patented neural network technology to clean ECG signals and deliver beat-by-beat PQRST labeling with time-series intervals. MaxYield-PPG extends this capability to photoplethysmography signals for wearables. Insight360 serves as the visualization and reporting layer, while CardioYield provides clinical review workflows. The company also offers vertical-specific solutions for animal/veterinary ECG, sports medicine, cardiac research, and wearable technology integration. All products are delivered via REST API, SDK, or CDK integration, positioning the company as a B2B technology provider to healthcare software companies, device manufacturers, and clinical organizations. Neural Cloud Solutions is a wholly owned subsidiary of AI/ML Innovations Inc. (CSE: AIML).

Differentiator

Problem solved

Functional benefit

Brands

  • MaxYield: Proprietary neural network intelligence layer that ingests raw ECG recordings from any device and returns clean, neuralized signals with beat-by-beat PQRST data. Includes MaxYield-ECG for electrocardiogram analysis and MaxYield-PPG for photoplethysmography signals.
  • Insight360
  • CardioYield

Products and services

  • MaxYield-ECG Device-agnostic ECG intelligence layer that maps through signal noise to isolate true ECG waveforms and delivers rapid, in-depth beat-by-beat PQRST labeling and time-series intervals (RR, PR, QT, QTc, ST). Delivered via REST API, SDK, or CDK integration as an additive layer for existing ECG workflows used by healthcare providers, device manufacturers, and OEMs.
  • MaxYield-PPG Photoplethysmography signal processing technology that applies Neural Cloud's neural network methodology to PPG signals from consumer wearables. Provides motion-artifact removal, heart-rate algorithm enhancement, ambient light interference compensation, skin tone adaptation, and HRV analysis for exercise-grade accuracy during high-intensity activities.
  • Insight360 Visualization and reporting layer that transforms MaxYield's quantified ECG data into customizable dashboards and reports. Features drag-and-drop widgets, configurable formulas (QTc, HRV, ST analysis), reusable templates, and HTML/PDF export for rapid clinical interpretation and scaled reporting throughput.
  • CardioYield AI-powered ECG visualization platform driven by MaxYield signal-processing technology for clinical workflows. Integrates with Holter monitoring to enable review, editing, and approval of flagged cardiac events with automated report generation and standardized structured outputs.
  • Animal & Veterinary ECG Solution Species-specific, beat-level ECG intelligence for animal and veterinary applications. Species-aware neural networks trained on species-specific morphologies for canine, equine, feline, porcine, rodent, and non-human primates, handling motion-heavy environments and extreme heart rate variability.
  • Wearable ECG Integration ECG signal enhancement solution for wearable technology companies. Provides clean, isolated ECG signals from smartwatches, smart rings, chest straps, and patch monitors, enabling product differentiation through superior signal quality and actionable cardiac insights.
  • Cardiac Research Solution ECG analysis solution for preclinical, clinical research organizations, and academic cardiac disease studies. Automated beat-by-beat tabulation for large-scale studies with standardized labeling, noise removal, and reproducible results supporting regulatory submissions.
  • Sports Medicine Solution ECG neural network for sports medicine and athletic performance monitoring. Analyzes cardiac data during high-intensity workouts from wearables and patch monitors, providing real-time feedback, trend analysis, and early detection of cardiac abnormalities related to overtraining.

Quantifiable outcome

  • Processing speed: 200,000 heartbeats analyzed in less than 2 minutes
  • +3 more outcomes

Companies that use Neural Cloud Solutions

Customer profile

Named customers5 records

Segments6 records

Ideal customer profiles4 records

Neural Cloud Solutions technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

Neural Cloud Solutions partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • European Digital Health PlatformcoreChannel Partner/ Reseller/ Distributor · 25 March 2026Reseller agreement to integrate and resell NeuralCloud's MaxYield ECG signal-processing technology for remote cardiac monitoring. Enables AI-driven ECG analysis to healthcare providers, transforming raw ECG signals into clean structured data for detecting cardiac abnormalities and supporting preventive cardiology.
  • Baker Heart and Diabetes InstitutecoreStrategic or Co-development Partner · 18 March 2026Research services agreement for AI-powered ECG signal processing in cardiovascular study examining heart rate variability in post-exertional malaise patients. NeuralCloud provides MaxYield platform to convert raw ECG recordings from PDF format into structured European Data Format for downstream HRV analysis. Findings expected to be published within the coming year.
  • Intelimed.ai SpAcoreChannel Partner/ Reseller/ Distributor · 18 February 2026Distribution agreement appointing Intelimed as exclusive distributor of Neural Cloud's cardiac software platforms (MaxYield, CardioYield, and Insight 360) in Chile and non-exclusive distributor across rest of Latin America. Targets hospitals, clinics, diagnostic providers, OEMs, telemedicine providers, and research institutions.
  • Lakeshore CardiologyminorStrategic or Co-development Partner · 12 December 2025Non-binding Commercial Agreement Term Sheet to integrate CardioYield AI-powered ECG visualization platform driven by MaxYield signal-processing technology into Lakeshore Cardiology's clinical workflows for Holter monitoring. Staged rollout: internal validation, paid trial, full system integration, and commercial availability pending Health Canada clearance.

Scale indicators4 records

Recent moves6 records

Expansion highlights7 records

Neural Cloud Solutions competitors and assessment

Company assessment

Direct peers

  • HeartBeam: HeartBeam develops AI-enabled ECG technology for cardiac event detection and remote monitoring. Comparable as a small-cap digital health company focused on AI-ECG innovation, though with a more device-centric product strategy than Neural Cloud's platform-software approach.
  • Eko Health: Eko Health develops AI-powered cardiac analysis (LUCAS for murmurs, AI ECG algorithms) used in clinical and point-of-care settings. Directly comparable to Neural Cloud as another AI-first ECG analytics provider integrating with stethoscopes and digital cardiac workflows.
  • iRhythm Technologies: iRhythm (Zio) combines wearable patch cardiac monitoring with proprietary AI-based ECG analysis for long-duration recordings. Highly comparable in scale-to-noise handling for extended Holter monitoring, the exact niche Neural Cloud targets with its 14.5-day continuous-recording capability.
  • AliveCor: AliveCor (KardiaMobile) builds AI-driven ECG analysis for consumer and clinical use, applying machine learning to single-lead ECG signals. Closely comparable product category (AI ECG), with both companies competing to license signal-intelligence IP to clinicians and device OEMs.
  • Cardiologs: Cardiologs (acquired by Philips) provides cloud-based AI ECG interpretation for Holter and ambulatory recordings, marketed to cardiology practices and IDTFs. Directly comparable in additive-layer positioning and target customer base, now operating inside a large incumbent.
  • VectraCor: VectraCor develops cloud-based AI ECG interpretation software (Vectraplex/EVOVIE) for clinicians. Comparable product offering (cloud ECG analysis) and customer segment (cardiologists and hospitals), though distributed primarily via direct enterprise sales.

Emerging players

  • Biotricity: Biotricity builds wearable cardiac monitoring devices (Bioflux) with cloud-based AI analysis for arrhythmia detection. Comparable in wearable-ECG + AI positioning though more vertically integrated on the hardware side than Neural Cloud's pure software/API approach.

Broad incumbents

  • GE Healthcare (ECG / MUSE): GE Healthcare's MUSE cardiology information system and resting ECG portfolio is widely deployed across US hospitals. A broad incumbent competitor for ECG analysis budgets, bundling analysis software with hardware and EMR integration.
  • Philips Cardiac Monitoring: Philips operates a large cardiac monitoring business spanning IntelliVue patient monitors, Holter/ambulatory ECG, and the Cardiologs AI ECG platform. Broad incumbent in the same category with overlapping ECG analytics capabilities and well-established hospital relationships.
  • Preventice Solutions (Boston Scientific): Preventice, now part of Boston Scientific, offers the BodyGuardian suite of wearable cardiac monitors with proprietary arrhythmia detection algorithms. Incumbent offering a vertically integrated monitor+AI+service stack that competes for IDTF and hospital Holter/ambulatory monitoring budgets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Neural Cloud Solutions social profiles

Digital presence

Neural Cloud Solutions compliance and trust

Trust signal

Compliance3 records

Neural Cloud Solutions financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Neural Cloud Solutions leadership team

Management profile

Number of profiles

Profiles6 records

Neural Cloud Solutions funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Neural Cloud Solutions M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neural Cloud Solutions

What does Neural Cloud Solutions do?

Neural Cloud Solutions develops and commercializes the MaxYield neural network platform for AI-powered ECG and PPG signal processing. The platform applies patented machine learning to clean noisy cardiac recordings from any device and deliver beat-by-beat PQRST labeling with precise onset/offset identification and time-series intervals (RR, PR, QT, QTc, ST). Products are delivered via REST API, SDK, and CDK integration to healthcare providers, medical device manufacturers, OEMs, and research organizations.

Is Neural Cloud Solutions a public or private company?

Neural Cloud Solutions is a private company. It is classified as corporate owned and is currently operating.

When was Neural Cloud Solutions founded?

Neural Cloud Solutions was founded in 2024. It employs 11 to 50 people.

Where is Neural Cloud Solutions based?

Neural Cloud Solutions is headquartered in Toronto, Canada, in the North America region.

How does Neural Cloud Solutions make money?

Three revenue lines are on record. API/SDK/CDK Subscriptions are the primary driver. The others are enterprise Licensing and partner/Reseller Revenue Share.

Who are Neural Cloud Solutions's main competitors?

Direct peers on record are HeartBeam, Eko Health, iRhythm Technologies, AliveCor, Cardiologs and VectraCor. Biotricity is listed as an emerging player. Broad incumbents are GE Healthcare (ECG / MUSE), Philips Cardiac Monitoring and Preventice Solutions (Boston Scientific).

Does Neural Cloud Solutions have an API?

Yes. REST API for ECG wave analysis. Developers can upload EDF (European Data Format) files for ECG analysis, query job status, and download CSV results containing P, QRS, and T wave onsets, offsets, and time-series intervals. Authentication uses Bearer token (API key). The API accepts ECG files via POST request to https://api.theneuralcloud.com/api/v1/ecg_wave_analysis and returns analysis results with output CSV files. Supports cloud-based batch processing and real-time analysis workflows. Developer documentation is at www.theneuralcloud.com/post/using-the-neural-cloud-rest-api-in-python.

What industry is Neural Cloud Solutions in?

Neural Cloud Solutions's product category is AI Cardiac Signal Processing Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLACAFAM, AI/Analytics for RPM (Risk Stratification, Alerts, Predictive). Its NAICS code is 54151 and its SIC code is 7374.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The future of tradingAIML unit NeuralCloud signs binding commercial term sheet with VetMed for MaxYield ECG servicesNeuralCloud, a unit of AI/ML Innovations, signed a binding term sheet with VetMed Consultants to evaluate MaxYield ECG processing. The deal sets a phased validation path for VetMed's preclinical cardiac safety work, with initial testing using anonymized ECG files and later phases targeting GLP-aligned controls.YahooAI/ML Innovations subsidiary NeuralCloud Appoints Former FDA Reviewer Dr. Mehmet Kosoglu as the Head of Regulatory AffairsNeuralCloud Solutions, a subsidiary of AI/ML Innovations, appointed Dr. Mehmet Kosoglu as Head of Regulatory. He brings over 15 years of FDA review experience and will support the company's AI-powered cardiac technologies, including MaxYield and CardioYield. The appointment follows NeuralCloud's ISO 13485:2016 MDSAP certification.Stock TitanAI/ML Innovations Signs CardioYield Pilot Term SheetAI/ML Innovations Inc. announced that its subsidiary, NeuralCloud Solutions, signed a non-binding term sheet with Island Mobile Cardiology Testing to pilot its CardioYield and MaxYield AI platforms for mobile Holter monitoring. The pilot will evaluate the technology's performance in real-world workflows through retrospective analysis of anonymized ECG data before potential future integration. This development is contingent upon pending regulatory clearances from Health Canada and the U.S. FDA.FinanzNachrichten.deNeuralCloud, eine Tochtergesellschaft von AI/ML Innovations, erhält die Zertifizierung nach ISO 13485: 2016 (MDSAP)NeuralCloud Solutions Inc., a subsidiary of AI/ML Innovations Inc., has obtained ISO 13485:2016 certification under the Medical Device Single Audit Program (MDSAP) for its quality management system regarding EKG software-as-a-medical-device. This certification, issued by TÜV USA, Inc., validates the company's regulatory readiness and quality framework for developing cardiac diagnostic AI technologies across multiple jurisdictions including Canada, the US, Australia, Brazil, and Japan. The achievement marks a strategic milestone in preparing NeuralCloud for future product approvals and commercialization in the regulated digital health market.FinanzNachrichten.deePropelled baut seine Produktionsflächen mit 60 Millionen $ an Fördermitteln der US-Regierung aus, um die Lieferkette für Drohnenantriebe in den USA zu stärkenAI/ML Innovations Inc. announced that its subsidiary NeuralCloud Solutions Inc. has received ISO 13485:2016 certification under the Medical Device Single Audit Program (MDSAP) for its EKG software-as-a-medical-device platform. This certification validates the company's quality management system for the design and development of cardiac analysis technologies, facilitating regulatory readiness across multiple jurisdictions including Canada, the US, Australia, Brazil, and Japan. The achievement supports NeuralCloud's strategy to deploy scalable AI-powered heart diagnostics in clinical and telemedicine settings.Via TTAI/ML Innovations' Subsidiary NeuralCloud Achieves ISO 13485:2016 (MDSAP) CertificationAI/ML Innovations Inc. announced on August 11, 2026 that its subsidiary NeuralCloud Solutions Inc. has received ISO 13485:2016 certification under the Medical Device Single Audit Program from TÜV USA, Inc. The certification covers NeuralCloud's quality management system for ECG software-as-a-medical-device platforms, including MaxYield and CardioYield. MDSAP is voluntary in the U.S. but mandatory in Canada, and the FDA will accept its audit reports as a substitute for routine inspections.Stock TitanAI/ML Innovations wins U.S. patent for ECG AIAI/ML Innovations Inc. announced that its wholly owned subsidiary NeuralCloud Solutions Inc. has been granted U.S. Patent No. 12,622,625 B2 by the USPTO, covering machine learning techniques for ECG analysis including denoising, rhythm classification, sample-level labelling, wearable cardiac monitoring, and report generation. The patent expands the company's intellectual property portfolio around its AI-driven ECG analysis architecture and is intended to strengthen NeuralCloud's competitive position across ambulatory monitoring, remote patient monitoring, telecardiology, and OEM integrations. The company also disclosed a debt settlement agreement to issue 3,560,334 common shares at CDN$0.05 per share to certain service providers, subject to Canadian Securities Exchange approval.Stock TitanAI/ML's NeuralCloud names Dale, Nick DuBois to ECG rolesAI/ML Innovations Inc. appointed Dale and Nicholas DuBois to lead clinical and overread operations at its subsidiary, NeuralCloud Solutions Inc. The appointments aim to strengthen the company's clinical-governance and operational readiness as it advances its neural-network ECG signal-processing technology through regulatory review. This strategic hiring brings over 50 years of combined cardiac monitoring experience to support the technology's path toward potential future commercialization.Stock TitanAIML Innovations unit signs Europe ECG reseller dealAI/ML Innovations Inc.'s wholly owned subsidiary Neural Cloud Solutions Inc. signed a reseller agreement on March 25th, 2026 with a European-based digital health platform to integrate and resell Neural Cloud's MaxYield™ ECG signal-processing technology for remote cardiac monitoring. The partnership enables the European platform to offer AI-driven ECG analysis to healthcare providers, transforming raw ECG signals into clean, structured data for detecting cardiac abnormalities and supporting preventive cardiology. The agreement reflects Neural Cloud's strategy to embed its ECG signal-processing capabilities within a growing ecosystem of digital health platforms and clinical software systems.YahooNeural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring PlatformNeural Cloud Solutions Inc., a wholly owned subsidiary of AI/ML Innovations Inc., entered into a reseller agreement on March 25, 2026 with a European-based digital health platform specializing in cloud-based ECG and heart rate variability analytics. Under the agreement, the partner platform will integrate and resell Neural Cloud's MaxYield™ ECG signal-processing technology as a standalone capability or as part of bundled remote cardiac monitoring solutions. The collaboration aims to expand access to advanced ECG signal analysis for healthcare providers and remote monitoring programs serving patient populations.